What's Happening?
Congress is actively considering new legislation aimed at regulating the use of Artificial Intelligence (AI) in healthcare. Key proposals include the Protecting Americans Through Intelligent, Ethical, and Transparent Artificial Intelligence in Health
Care Act (PATIENT AI Act) and the Doctors Not AI Act. The PATIENT AI Act, a discussion draft from Senate HELP Committee Chairman Bill Cassidy, focuses on U.S. Food and Drug Administration (FDA) and Office of the National Coordinator for Health Information Technology (ONC) oversight of AI-based health technologies, FDA review of software changes, Department of Health and Human Services (HHS) guidance on AI privacy and security, and a payment pathway for qualifying AI technologies. Meanwhile, the bipartisan House proposal, the Doctors Not AI Act of 2026, specifically targets AI use in health plan coverage decisions, seeking to prohibit AI systems from making or dictating adverse benefit determinations that involve clinical judgment. This bill would require such decisions to be made by appropriately trained and licensed healthcare professionals, while still allowing AI to assist with administrative claims processing. These legislative efforts reflect growing congressional attention to AI's role in healthcare, encompassing reimbursement, regulatory oversight, privacy, security, and the appropriate balance between AI and human decision-making.
Why It's Important?
The proposed legislation is crucial for establishing a federal framework for AI in healthcare, an area currently experiencing rapid technological advancement and increasing integration. The PATIENT AI Act aims to provide clarity on regulatory oversight and create pathways for the reimbursement of AI technologies, which could significantly impact the development and adoption of new AI-driven medical tools. For healthcare providers and technology developers, a clear payment pathway and defined regulatory guidelines could reduce uncertainty and foster innovation. The Doctors Not AI Act addresses a critical ethical and practical concern: ensuring human involvement in sensitive clinical judgment decisions related to health plan coverage. This could protect patients from potentially biased or erroneous algorithmic determinations and maintain the role of medical professionals in critical care decisions. Without such regulations, there is a risk of fragmented state-level laws, which could create a complex and costly compliance landscape for companies operating across different states, potentially hindering the widespread and equitable adoption of beneficial AI technologies in healthcare.
What's Next?
Neither the PATIENT AI Act nor the Doctors Not AI Act has progressed beyond their initial legislative stages. Their future advancement will depend on congressional priorities and leadership in the upcoming Congress. However, these proposals signal a clear intent from federal lawmakers to address the evolving landscape of AI in healthcare. Stakeholders, including AI developers, healthcare providers, insurance companies, and patient advocacy groups, will likely continue to engage with lawmakers to shape these bills. The Centers for Medicare & Medicaid Services (CMS) is also exploring how Medicare payments should account for AI-enabled care and has issued requests for information on the payment implications of technology-enabled primary care. This ongoing dialogue and legislative consideration suggest that federal policy on healthcare AI will continue to evolve, with potential for new regulations and guidelines to be introduced or refined in the coming years.
Beyond the Headlines
The debate surrounding AI regulation in healthcare extends beyond immediate policy and economic impacts, touching upon fundamental ethical and societal questions. The 'Doctors Not AI Act' highlights the tension between efficiency gains offered by AI and the imperative to maintain human oversight in critical areas like clinical judgment. This raises broader questions about accountability when AI contributes to patient harm, a concern the American Medical Association (AMA) has begun to address with its own clinical AI liability framework. This framework suggests allocating responsibility based on each party's authority, access to information, and ability to control or mitigate risk, challenging the assumption that simply having a physician 'in the loop' absolves developers or health systems of responsibility. The discussion also underscores the need for multidisciplinary expertise in AI governance, combining technical knowledge with medical, legal, ethical, and societal perspectives to ensure that AI development and deployment prioritize patient and public interests.
